8-K · Director/officer change
EDGARProvectus Biopharmaceuticals Inc
Provectus Biopharmaceuticals Inc (PVCT) SEC filings
Provectus Biopharmaceuticals Inc (PVCT) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.
Those exhibit numbers sit next to the income-statement cache: Latest reported PVCT revenue for 2025-09-30 was $336.1K. Net income was -$1.3M. PVCT currently screens at market cap $25.9M. The PVCT filings page is the source view; the stock page is the research view.
EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Provectus Biopharmaceuticals Inc said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.
Recent filings
8-K · Shareholder vote results
EDGARSource: SEC EDGAR · Latest filing Jul 1, 2026
PVCT SEC filings FAQ
What is the latest PVCT SEC filing?
The latest cached Provectus Biopharmaceuticals Inc (PVCT) filing on this page is 8-K · Jul 1, 2026. Filings: https://lician.com/sec/pvct
What is the latest PVCT filing accession number?
The latest cached Provectus Biopharmaceuticals Inc (PVCT) accession number on this page is 0001493152-26-031379. Filing: https://lician.com/sec/pvct/0001493152-26-031379
Which item code is on the latest PVCT filing?
Cached item code on the latest Provectus Biopharmaceuticals Inc (PVCT) 8-K is 5.02.
How many PVCT SEC filings are listed on this page?
This page lists 2 cached Provectus Biopharmaceuticals Inc (PVCT) SEC filings. Filings: https://lician.com/sec/pvct
What are PVCT's latest revenue and net income?
Latest cached Provectus Biopharmaceuticals Inc (PVCT) revenue for Sep 30, 2025 was $336.1K. Net income was -$1.3M. Statements: https://lician.com/financials/pvct